Authors
Latest:
Amy Sullivan, PsyD: Personalized Approach to Fatigue in Multiple SclerosisThe Director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about how she approaches fatigue in MS from a behavioral standpoint.
Latest:
Jeff Waugh, MD, PhD: Viewing Striatal Injury More GranularlyDespite some mistrusting the abilities of imaging to aid in therapeutic development, a new MRI method could better inform the anatomical understanding of the striatum.
Latest:
Ofatumumab and the Anti-CD20 ClassAn expert discusses takeaways about the anti-CD20 monoclonal antibody class of disease-modifying therapies for patients with relapsing multiple sclerosis through the lens of ofatumumab (Kesimpta; Novartis).
Latest:
Dominic Pelle, MD: Improving Patient-Reported Outcomes in Spine SurgeryThe spine surgeon in the Center for Spine Health at Cleveland Clinic spoke to the importance of improving patient-reported outcomes and ensuring consistent communication with patients undergoing spine surgery.
Latest:
Current and Future Landscape of Alzheimer Disease Treatment: Emergence of Disease Modifying TherapiesAfter years of failed drug development, the thoughts of disease-modifying therapies for Alzheimer disease are starting to become real.
Latest:
Jerrold L. Vitek, MD, PhD: Multiple Independent Contact Current-Controlled DBS TechnologyThe professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.
Latest:
Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic HeadacheMia Minen, MD, MPH, sat down for an interview to discuss why behavioral therapies could be an effective and easily accessible treatment for posttraumatic headaches following events like concussions.
Latest:
Eugenia Trushina, PhD: Communication and Learning Through CollaborationFor the associate professor of neurology, learning, listening, and collaborating are the keys to improving the field of care.
Latest:
Chia-Chun Chiang, MD: Collecting Real-World Data Following FDA ApprovalsThe neurologist at Mayo Clinic in Phoenix, Arizona, detailed the importance of further studies of FDA approved medications in different patient populations.
Latest:
The Potential of Blood Tests to Improve Screening and Monitoring in Alzheimer Disease Clinical Trials: Ronald C. Petersen, MD, PhDThe director of the Alzheimer’s Disease Research Center at Mayo Clinic detailed the current issues with access and affordability to critical biomarkers in the screening and monitoring of patients in Alzheimer disease trials. [WATCH TIME: 3 minutes]
Latest:
The Importance of a Globally Aligned, Standardized MRI Protocol for MSLeaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.
Latest:
Pimavanserin Safety Data and Future Research: Clive Ballard, MDClive Ballard, MD, spoke on the safety data of pimavanserin, which was presented at the 2021 AAIC meeting, held from July 26-30.
Latest:
Ari Green, MD, MCR: Remyelination in Multiple SclerosisThe medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.
Latest:
Rare Epilepsies, Comorbidities, and Genetic Therapies: Danielle Andrade, MD, MSc, FRCPCThe professor of neurology at the University of Toronto talked about 3 conditions that were discussed during the epilepsy therapies symposium at the 2022 AES Conference. [WATCH TIME: 5 minutes]
Latest:
Deborah Friedman, MD, MPH: Coordinating Care in TelemedicineThe professor of neurology, neurotherapeutics, and ophthalmology at UT Southwestern discussed the need to better coordinate care between providers when telemedicine is being utilized in headache and migraine care.
Latest:
Trevor Dyson-Hudson, MD: Unseen Consequences of Spinal Cord InjuryThe director of the Center for Spinal Cord Injury Research and co-director of the Spinal Cord Injury Model System Center at Kessler Foundation discussed the secondary medical complications of spinal cord injury and how he and colleagues seek to alleviate them.
Latest:
Treating MS: A Simplified Strategy Boosts Patient and Provider SatisfactionBoth the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.
Latest:
Novel and Emerging Targets in Multiple SclerosisExperts in neurology share their hopes for the future of multiple sclerosis treatment and discuss unmet needs and novel targets.
Latest:
Paul Newhouse, MD: Muscarinic Agonists in Alzheimer TreatmentThe Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine shared how the previous muscarinic agonists have better informed the development of this investigational agent, VU319.
Latest:
The “Grave Threat” Posed by the Shortage of NeurologistsWith the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.
Latest:
Peii Chen, PhD: Addressing Spatial Neglect After StrokeThe senior research scientist at Kessler Foundation offered her personal experience in treating spatial neglect in patients with stroke and potential future treatments on the way.
Latest:
This Week on NeurologyLive® — March 27, 2023Here's some of what is coming soon to NeurologyLive® this week.
Latest:
John Corboy, MD: The DISCO-MS TrialThe professor of neurology at Colorado University spoke about the ongoing phase IV trial to determine the safety of DMT discontinuation in MS.
